Prognostic value of dobutamine-atropine stress myocardial perfusion imaging in patients with diabetes

Diabetes Care

Volumn 25, Issue 9, 2002, Pages 1637-1643

  Schinkel, Arend F L ^a   Elhendy, Abdou ^a   Van Domburg, Ron T ^a   Bax, Jeroen J ^a   Vourvouri, Eleni C ^a   Sozzi, Fabiola B ^a   Valkema, Roelf ^a   Roelandt, Jos R T C ^a   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DOBUTAMINE; ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAGNOSTIC AGENT;

ARTICLE; CARDIOVASCULAR EFFECT; CONFIDENCE INTERVAL; DIABETES MELLITUS; DIAGNOSTIC VALUE; EXERCISE; EXERCISE TEST; FOLLOW UP; HAZARD ASSESSMENT; HEART DEATH; HEART INFARCTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; IMAGING; MAJOR CLINICAL STUDY; PROGNOSIS; REVASCULARIZATION; STRESS; AGED; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; SUDDEN DEATH; SURVIVAL;

AGED; ATROPINE; CORONARY CIRCULATION; DEATH, SUDDEN, CARDIAC; DIABETES MELLITUS, TYPE 1; DOBUTAMINE; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PARASYMPATHOLYTICS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; SYMPATHOMIMETICS;

EID: 0036726376     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.9.1637     Document Type: Article

References (27)

1. Kannel WB, McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care 2:120-126, 1979
2. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100:1134-1146, 1999
3. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
4. Burke JP, Williams K, Gaskill SP, Hazuda HP, Haffner SM, Stern MP: Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med 159:1450-1456, 1999
5. Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner SM, Pyorala K, Tuomilehto J: Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care 21:69-75, 1998
6. Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB, Turi ZG, Strauss HW, Willerson JT, Robertson T, Braunwald E, Jaffe AS: The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary artery disease and diastolic left ventricular dysfunction to the adverse prognosis: the MILIS Study Group. J Am Coll Cardiol 14:49-57, 1989
7. Chiariello M, Indolfi C: Silent myocardial ischemia in patients with diabetes mellitus. Circulation 93:2089-2091, 1996
8. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V: Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 22:1396-1400, 1999
9. Smith JW, Marcus FI, Serokman R: Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol 54:718-721, 1984
10. Mak KH, Moliterno DJ, Granger CB, Miller DP, White HD, Wilcox RG, Califf RM, Topol EJ: Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction: GUSTO-I Investigators: Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 30:171-179, 1997
11. The Bypass Angioplasty Revascularization Investigation (BARI) investigators: Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335:217-225, 1996
12. Detre KM, Lombardero MS, Brooks MM, Hardison RM, Holubkov R, Sopko G, Frye RL, Chaitman BR, for the Bypass Angioplasty Revascularization Investigation Investigators: The effect of previous coronary artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. N Engl J Med 342:989-997, 2000
13. Felsher J, Meissner MD, Hakki AH, Heo J, Kane-March S, Iskandrian AS: Exercise thallium imaging in patients with diabetes mellitus. Arch Intern Med 147:313-317, 1987
14. Vanzetto G, Halimi S, Hammoud T, Fagret D, Benhamou PY, Cordonnier D, Denis B, Machecourt J: Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Diabetes Care 22:19-26, 1999
15. Cohen MC, Curran PJ, L'Italien GJ, Mittleman MA, Zarich SW: Long-term prognostic value of preoperative dipyridamole thallium imaging and clinical indexes in patients with diabetes mellitus undergoing peripheral vascular surgery. Am J Cardiol 83:1038-1042, 1999
16. Kang X, Berman DS, Lewin HC, Cohen I, Friedman JD, Germano G, Hachamovitch R, Shaw LJ: Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 138:1025-1032, 1999
17. Elhendy A, Arruda AM, Mohoney DW, Pellikka PA: Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol 37:1551-1557, 2001
18. Jorgensen H, Nakayama H, Raaschou HO, Olsen TS: Stroke in patients with diabetes: the Copenhagen Stroke Study. Stroke 25:1977-1984, 1994
19. Akbari CM, LoGerfo FW: Diabetes and peripheral vascular disease. J Vasc Surg 30:373-384, 1999
20. May O, Arildsen H, Damsgaard EM, Mickley H: Cardiovascular autonomic neuropathy in insulin-dependent diabetes mellitus: prevalence and estimated risk of coronary heart disease in the general population. J Intern Med 248:483-491, 2000
21. Geleijnse ML, Elhendy A, Van Domburg RT, Cornel JH, Reijs AEM, Roelandt JRTC, Krenning EP, Fioretti PM: Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain. J Am Coll Cardiol 28:447-454, 1996
22. Senior R, Raval U, Lahiri A: Prognostic value of stress dobutamine technetium-99m sestamibi single-photon emission computed tomography (SPECT) in patients with suspected coronary disease. Am J Cardiol 78:1092-1096, 1996
23. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, Diamond GA: Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 93:905-914, 1996
24. Elhendy A, Valkema R, van Domburg RT, Bax JJ, Nierop PR, Cornel JH, Geleijnse ML, Reijs AE, Krenning EP, Roelandt JRTC: Safety of dobutamine-atropine stress myocardial perfusion scintigraphy. J Nucl Med 39:1662-1666, 1998
25. Cox DR: Regression models and life-tables. J R Stat Soc (B) 34:187-202, 1972
26. Geleijnse ML, Elhendy A, Fioretti PM, Roelandt JRTC: Dobutamine stress myocardial perfusion imaging. J Am Coll Cardiol 36:2017-2027, 2000
27. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, Borges-Neto S, Berman DS, Waters DD, Heller GV: Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 105:32-40, 2002